JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation [Yahoo! Finance]
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Jasper Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
Form 8-K Jasper Therapeutics, For: Dec 02
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.